Esculentin-2CHa [C31S, C37S]
General Information
DCTPep ID DCTPep02338
Peptide Name Esculentin-2CHa [C31S, C37S]
Sequence GFSSIFRGVAKFASKGLGKDLAKLGVDLVASKISKQS
Sequence Length 37
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
ACP Tumor active peptide
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
A549 | Lung adenocarcinoma | LC50=26 μM | CellTiter-Glo Luminescent Cell Viability assay | 24 h | 1 |
Hemolytic Activity Human erythrocytes: 50% Hemolysis>200 µM
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure DCTPep02338
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C173H289N47O49
Absent amino acids CEHMNPTWY
Theoretical pI 10.30
Acidic residues 2
Basic residues 7
Polar residues 11
Molecular weight (Average) 3811.48
Molecular weight (Monoisotopic) 3809.16
Common amino acids KS
Net charge 5
Instability index (II) 17.68
Aliphatic index 97.57
Grand average of hydropathicity (GRAVY) 0.195
Half Life
30 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Extinction coefficients
Should not be visible by UV spectrophotometry.
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 23159562
Title Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells
Doi 10.1016/j.peptides.2012.11.004
Year 2013
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_4387